Background/Aims: We aimed to explore the protective role of curcumin (Cur) in a cell model of Parkinson's disease (PD) and its underlying mechanism. Methods: In this study, genes concerned with PD-related keywords were screened within DiGSeE database. The association network between Cur and selected genes was downloaded from STITCH, with the interactions analyzed by STRING. We built a mitochondrial toxin 1-methyl-4-phenylpyridinium (MPP + )-induced SH-SY5Y cell model of PD. Cell morphology was observed under an electron microscope. MTT assay was applied to detect cell proliferation rate. Western blot assay was conducted to determine the level of apoptotic markers, including cleaved caspase 3, Bcl-2-associated X protein (Bax) and B-cell lymphoma-extra-large (Bcl-xl). Tyrosine hydroxylase (TH), dopamine transporter (DAT) protein levels and dopamine (DA) concentration were identified as dopaminergic neuron markers and measured by western blotting or Enzymelinked immunosorbent assay (ELISA). Results: Cur rescued the toxicity effects of MPP + on SH-SY5Y cells, by controlling morphological change, promoting cell proliferation and inhibiting apoptosis. Of all PD-related genes, HSP90 played an important role in Cur-gene network. HSP90 protein level was elevated by MPP + , whereas Cur could reverse this effect. Silencing of HSP90 significantly attenuated the curative effect introduced by Cur, while HSP90 overexpression enhanced the impact of Cur on PD. Conclusion: Cur can effectively inhibit the toxic effect of MPP + on SH-SY5Y cells and significantly reduce the adverse effects of MPP + on dopaminergic neurons via up-regulation of HSP90.
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by reduced dopaminergic neurons in substantia nigra pars compacta (SNc) and accumulated misfolded α-synuclein protein to generate eosinophilic protein deposits (Lewy bodies) [1, 2] . These characteristics account for clinical symptoms of PD, including bradykinesia, rigidity, tremor and postural instability; however, PD is presented as a multisystem disorder, which leads to other non-motor defects such as cognitive dysfunction and sleep disturbance during progression [3] . PD is ranked as the 2 nd most common neurodegenerative disorder just after Alzheimer's disease as it affects approximately 1% of persons aged above 65 and almost 3% of those over 80 [3] . Aging being the greatest risk factor, PD patient number is still at rise and is estimated to duplicate by year 2030 [3, 4] . The etiology of PD has not been fully revealed, but a combination of genetic and environmental factors has often been involved in current literature [2] . As for the environmental approach, the development of PD models introduced by chemicals such as 1-methyl-4-phenyl-1, 2-3, 6-tetrahyrdopyridine (MPTP) or 1-methyl-4-phenyl-pyridiniumion (MPP + ) has conditioned further investigations into PD [1, 4] . Genetic studies have found genes such as SNCA, LRRK2, PINK1, DJ-1, ATP13A2 and CHCHD2 to be correlated with PD [2] . A study of van de Merwe et al. proposed that curcumin (Cur) protected against PD injury in a PINK1-knockdown cell model [2] . Cur, or diferuloylmethane, is a natural ingredient extracted from Curcuma longa rhizome [5, 6] . It has attracted great interest for its numerous pharmacological properties such as anti-inflammation, antioxidant, anti-tumor and anti-nerve degeneration [2, 7] . Previous studies suggested that Cur could be used in PD treatment in vivo [8] . For instance, Liu et al. demonstrated that Cur was protective in PC12 cell models of PD stimulated by A53T α-synuclein [9] . Yu et al. investigated via an MPP + -introduced PD model suggested that the anti-inflammatory and anti-oxidative roles of Cur were by interacting with TLR4 and its downstream effectors [5] . Cui et al. emphasized its mitigation on PD dopaminergic neural damage, of which increased tyrosine hydroxylase (TH) activity was included as a parameter [8] . However, the underlying mechanism of Cur being anti-PD has not been fully understood [7] .
The 90-kDa heat shock protein (Hsp90) belongs to the heat shock proteins (HSPs), which serve as molecular chaperons to assist protein folding, stabilization and activation, etc. [10, 11] . HSPs will be raised by cellular stress, but remain at a low level in healthy conditions [12] . Hsp90 is a major therapeutic target in cancer studies, but more recently it is focused for a curative role in neurodegenerative disorders [11] . In PD, Aridon et al. argued that Hsp70 and Hsp90 prevented protein misfolding and repressed neuron apoptosis [12] . Daturpalli et al. found that Hsp90 prevented α-synuclein accumulation and Lewy body formation to protect against PD [11] . Curcumin was used to treat various diseases through altering HSPs expression in many reports. For instance, Lv et al. had reported that curcumin inhibited heat shock protein 90 (Hsp90) increase in HCMV infection of human embryonic lung fibroblast cells through hydrogen bonds, hydrophobic interactions and conjugation to bind with Hsp90 [13] . Additionally, curcumin attenuated selenite-induced cataract through the reduction of Hsp70 and other intracellular production of reactive oxygen species [14] . Among the PD related genes, HSP90 showed the direct interaction with curcumin in this study, besides that the combination therapy of curcumin and HSP90 for Parkinson has not yet been investigated. In this study, we applied bioinformatic analysis to screen out Cur-and PD-related genes to investigate the underlying mechanism of Cur in preventing against PD injury. MPP + -stimulated SH-SY5Y cell models were built for experimental study. Cell proliferation, apoptosis and morphology were taken as criteria for MPP + cytotoxicity. Dopaminergic neuron markers were measured by western blotting and enzyme-linked immunosorbent assay (ELISA). Our research suggested that Cur improved PD cells' survival rate, which could be improved by HSP90 overexpression. 
Transfection
Overexpression vectors of HSP90 (ov-HSP90) and short interference RNA siRNA of HSP90 (si-HSP90) for transfection were purchased from GenePharma (Shanghai, China). Before transfection, the cells were starved for 6 h with 2% FBS culture condition. The transfection was performed via Lipofectamine 3000 (Life Technologies, USA) according to the manufacturer's protocols. During the transfection, cells were under free-FBS condition. After 6 h transfection, the culture was refreshed with whole medium culture (10% FBS, high-glucose DMEM). All the following experiments were conducted after 24 h transfection. The control group in Fig. 1 was transfected with nothing but transfection reagent.
MTT assay
MTT assay was used to detect the effects of drugs on cell viability. MTT Cell Proliferation Kit and Cytotoxicity Assay Kit were purchased from Sangon Biotech (Shanghai, China) and were used to perform MTT assay. After 12 h treatment of 0 μmol/L, 50 μmol/L, 100 μmol/L, 200 μmol/L, 400 μmol/L or 800 μmol/L (μM) MPP + with or without 40 μmol/L curcumin (Cur), the viability of SH-SY5Y cell was identified via MTT assay. 1 mg MTT was added to each milliliter of medium and incubated at 37 °C for 4 h. After 4 h, the medium in the plate was discarded, and 200 μL dimethylsulphoxide (DMSO) was added to each well before one-minute shaking for dissolution in a microplate reader (BioRad Model 680; Bio-Rad, Hercules, CA, USA). The absorbance of each well was measured at 570 nm, and the cell growth curve was plotted based on an average of five wells. The absorbance of control group (0 μmol/L MPP + or only transfection reagent) was normalized as 100% and the other groups were compared with it. The experiment was repeated in triplicate.
Western blot SH-SY5Y PD cells treated with or without Cur were lysed in radio-immunoprecipitation assay (RIPA) buffer (BioVision, Milpitas, CA, USA). Then cells were sonicated and centrifuged for complete lysis. Total protein in supernatants was quantified using BCA-200 protein assay kit (Pierce Biotechnology, Rockford, IL, USA). 20 μL of samples were mixed with loading buffer and dithiothreitol (DTT) at a ratio of 8:10:2, and then boiled for 5 min. The protein was separated with 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a polyvinylidene fluoride (PVDF) membrane (500 mA). The membrane was sealed up in Tris Buffered Saline Tween (TBST) with 5% skim milk at room temperate for 1 h, and subsequently cultured with primary antibodies including anti-Tyrosine Hydroxylase (ab112, 0.75µg/mL ; Abcam Inc., Cambridge, MA, USA), anti-Dopamine Transporter (ab111468, 1 µg/mL), anti-Hsp90 (ab13495, 0.5 µg/mL), anti-cleaved-Caspase 3 (ab2302, 1 µg/mL), anti-Bcl-XL (ab2568, 1 µg/ mL), anti-Bax (ab32503, 0.1 µg/mL), anti-β-actin (ab179467, 0.1 µg/mL) and anti-Tubulin (ab6160, 1 µg/ mL) at 4 °C for one night. After TBST-washing in triplicate, the membrane was incubated for 1 h at room temperature with secondary antibody Goat anti-Rabbit IgG H&L (HRP) (ab6721, 0.1 µg/mL). Protein bands were visualized using enhanced chemiluminescence (Santa Cruz Biotechnology; Santa Cruz, CA, USA). Quantity One software (Bio-Rad) was used for image analysis. The results were analyzed by Image Pro Plus 5.0 (Media, Cybernetics, USA). Tubulin and β-actin were included as internal controls. The experiment was repeated in triplicate.
ELISA
Human Dopamine (DA) ELISA Kit (MBS045009; MyBioSource, San Diego, CA; sensitivity: 1.0 pg/mL) was used for determination of DA concentrations in SH-SY5Y cells treated with variations of MPP + and Cur for 24 h according to the manufacturer's instructions. We measured sample absorbance at 450 nm. The experiment was repeated in triplicate.
Data processing
Data were shown as mean ± SEM (standard error of mean). All analysis was done in SPSS 10.0 software. Comparisons were conducted by one-way or two-way ANOVAs, along with Newman-Keuls or Bonferroni correction for multiple comparison tests. P<0.05 was regarded as statistically significant. (Fig.  2C, P<0.05) . Western blot was conducted to detect the protein level of pro-apoptotic factors cleaved-caspase 3, Bax and anti-apoptotic Bcl-xl after 24 h cultivation in MPP + (400 μM) with or without Cur (40 μM). Comparing normal group, MPP + (400 μM) significantly increased cleaved-caspase 3 and Bax level and cut down Bcl-xl level, which indicated promotion in apoptosis rate. Cur (40 μM) in turn reversed this trend (Fig. 2D, P<0.05) . The results of Western blot on TH and DAT were shown in Fig. 2E . MPP + (400 μM) could induce cytotoxicity, which significantly decreased the protein level of TH and DAT. The addition of Cur (40 μM) could reduce MPP + -introduced cytotoxicity as reflected by recovered protein level of TH and DAT. Therefore, Curcumin protected dopaminergic neurons against MPP + toxicity.
Results

Curcumin relieved the alternation of SH-SY5Y cells introduced by MPP
HSP90 was identified as the core gene correlated with Cur
"Parkinson Disease", "Parkinson Disease, Secondary" and "Parkinsonian Disorders" in Nervous System Diseases were put into the database of DiGSeE to probe for PD-related genes. After deletion of duplicate values, 491 related genes were selected by "Parkinson Disease", 64 by "Parkinson Disease, Secondary", and 1101 by "Parkinsonian Disorders" (Table S1 - 
Cur alleviated MPP + -induced injury via HSP90
Following the bioinformatic analysis, western blotting was performed to explore the role of Cur on HSP90 expression in PD. The results of western blot showed that the HSP90 protein level in SH-SY5Y cell models induced by MPP + (400 μM) was significantly higher compared with the control group (P<0.05), which indicated that MPP + promoted the expression of HSP90. The addition of Cur (40 μM) could significantly reduce this uplift, and therefore diminished the toxic effects induced by MPP + (Fig. 1A, P<0.05) . Hence, we hypothesized that HSP90 was involved in the manipulation of Cur on PD.
To evaluate the function of HSP90 in the process of Cur treatment on PD cell models, we transfected SH-SY5Y cells incubated with or without Cur (40 μM) and MPP + (400 μM) with overexpression vector (HSP90+) and short interference RNA (siRNA) to upregulate and knockdown the protein level of HSP90 (HSP90-) (Fig. 1B and Fig. S1A, P<0.05) . In an MTT assay, each group (HSP90-group and HSP90+ group) was compared with control group which transfected with nothing but transfection reagent and normalized as 100%. After downregulating HSP90, the rescue effect of Cur on PD-models with treatment of increasing concentrations of MPP + was not statistically significant as indicated by increasing survival rate. On the contrary, overexpressed HSP90 facilitated Cur (40 μM) treatment as indicated by similar survival rate compared to control group (without MPP + ) (Fig. 1C , ****P<0.0001, ns = no significance). As presented in Fig. 1D , there was a significant increase in DA concentration in HSP90+ group, indicating that HSP90 overexpression promoted the state of dopaminergic neuron (P<0.05). The level of apoptosis-related protein Cleaved-caspase 3 and Bax was increased by HSP90 knockdown and decreased by HSP90 overexpression, and that of Bclxl acted likewise yet with a reversed trend (Fig. 1E, P<0.05 ). Both implied that silencing of HSP90 introduced cell apoptosis. The weakening effect in the HSP90-group was also reflected by the detection of decreases in dopaminergic neuron markers TH and DAT by western blot (Fig. 1F, P<0.05) . However, regulating HSP90 alone on PD-models with MPP + (400 μM) showed no significance difference on the expression of those proteins (Fig. S1) . In a word, the combined treatment of Cur and HSP90 overexpression played a better role in improving MPP + -induced cytotoxicity in PD-cells (Fig. S2) .
Discussion
In the present study, we found a cell-protective effect of Cur in MPP + -induced SH-SY5Y cell models of PD. Cur treatment restored cell morphological change, increased cell survival rate, inhibited apoptosis and relieved dopaminergic neuron loss. HSP90 was detected as a core gene in correlation with both PD and Cur, and its protein level was upregulated in PD models. The rescuing effect of Cur was significantly attenuated by silencing HSP90 and facilitated by HSP90 overexpression. In a word, Cur protects against PD injury via HSP90.
Cur rehabilitated PD-cells in our observation, which is consistent with previous findings on similar therapeutic benefits. Yang et al. proposed that Cur reduced leucinerich repeat kinase 2 (LRRK2) activity in LRRK2-stimulated PD cell models and promoted recovery of LRRK2 transgenic drosophilae [15] . Singh et al. figured out the biophysical mechanism of Cur on treatment for PD that Cur bound to preformed oligomers and fibrils to prevent aggregation of α-synuclein [16] . Although some researchers highlighted the low bioavailability of curcumin in vivo, which was attributed to limited absorption and metabolic instability [17, 18] , stable analogs of Cur such as curcumin pyrazole and its derivative N-(3-Nitrophenylpyrazole) curcumin were utilized by Ahsan et al. to prevent neurotoxicity in PD along with other neurodegenerative diseases [17] . Ojha et al. reported that curcuminoid including curcumin, demethoxy curcumin and bis-demethoxy curcumin relieved dopaminergic neurodegeneration in MPTP-stimulated PD models [19] . In addition to naturally refined curcumin, semi-synthetic curcuminoid and its metal complexes were also potential therapeutic agents for PD treatment. [20] . The HSP family plays a major role in activating against protein misfolding in diseases including PD [21] . As reviewed by Lackie et al., early observation of Hsp90, Hsp70, Hsp60, Hsp40, and Hsp27 has provided a deeper insight into these chaperones [21] . For instance, Hsp60 was found to intervene in PD pathogenesis in 6-OHDA-lesioned rat models [22] . Hsp70 overexpression was reported to prevent α-synuclein accumulation and to reverse dopaminergic neuron loss [21] . Falsone et al. revealed that Hsp90 blocked α-synuclein aggregation in an in vitro model [23] . Hsp90 inhibition was a potential strategy to increase endogenous Hsp70 protein levels and further alleviated PD [4] . Hsp90 inhibitors may increase dopamine in PD, which could be potential therapeutic targets [24] .
Our study proved that Cur could decrease HSP90 expression in PD-cells, while overexpression of HSP90 improved therapeutic effect of Cur on PD mode cells, indicating there was a positive intermediate role of the combination of HSP90 and Cur. A growing body of researches has focused on Cur mechanism, such as activating the Akt/Nrf2 pathway, regulating nuclear factor kappa beta (NFκB) [8, 25] . The HSP-modulated Cur treatment of PD has rarely been touched. In our study, HSP90 was upregulated in SH-SY5Y cells treated with 400 μM MPP + . With treatment of Cur, HSP90 expression was decrease and cell survival rate was significantly increased. Moreover, overexpression of HSP90 was found to enhance the neuroprotective effect of Cur on PD models. However, overexpression of HSP90 alone did not provide sufficient neuroprotection in our results. Accordingly, we encouraged more studies to investigate the potential of combination therapy that includes both Cur and regulation of HSP90 protein in PD.
To our knowledge, it is the first time that the effect of combination therapy is implied in PD. However, some limitations exist in the current experiment. Thus, more experiments are required to verify the current point of view. For example, the underlying regulatory mechanism of HSP90 remains to be investigated. An in vivo study using MPTP-conditioned animal models is necessary to illustrate the potential value for clinical application. Furthermore, an increased survival rate of HSP90-transfected SH-SY5Y cells with increased MPP + concentration (200 to 800 μmol/L) may provide valuable evidence for demonstrating the impact of HSP90 on PD.
Conclusion
In summary, our research substantiated the neuroprotective role of Cur via HSP90 against PD toxicity. Cur reversed morphological change, restored cell survival rate, attenuated apoptosis and controlled dopaminergic neuron loss. Hsp90 protein level was promoted by MPP + -stimulation, and silencing of HSP90 reversed the protective effect of Cur. Meanwhile, we also verified that, combination therapy of Cur and Hsp90 protein would yield a better efficacy for PD.
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